Rheumatoid Arthritis Clinical Trial
Official title:
A Prospective Randomised Double Blind Single Centre Study Comparing Measured Resection and Ligament Balancing Implantation Techniques Using the Unity Knee™ Total Knee System
NCT number | NCT03511144 |
Other study ID # | CSP2015-04 |
Secondary ID | |
Status | Withdrawn |
Phase | N/A |
First received | |
Last updated | |
Start date | July 2018 |
Est. completion date | July 2020 |
Verified date | November 2018 |
Source | Corin |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
A comparison of two Unity Knee™ tissue-balancing techniques by analysing the results from X-rays and patient questionnaires.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | July 2020 |
Est. primary completion date | September 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Subjects suitable for the Unity Knee™ Total Knee System according to the product "Instructions for use" - Over 18 years old - Male and female subjects who are skeletally mature - Subjects who have a smartphone (iOS or Android) with internet connection via mobile Internet data or Wi-Fi connection - Subjects able to understand what is expected of them and be able to comply with the study protocol requirements Exclusion Criteria: - Any subject listed for a revision total knee replacement or conversion of a unicondylar replacement to a total knee replacement on the operative knee - Any subject with fixed flexion contracture greater than 20 degrees - Any subject with varus/valgus deformity greater than 15 degrees - Any subject with confirmed osteoarthritis or other pathologies affecting the contralateral knee that is anticipated to require surgery within 12 months - Any subjects with contralateral knee replacement that is anticipated to require revision surgery within 12 months - Any subject whose prospects for a recovery to independent mobility would be compromised by known co-existent, medical problems - Any subject with a known sensitivity to device material - Any subject who is pregnant - Any subject currently a prisoner - Any subject known to be a drug or alcohol abuser, or have a psychological disorder that could affect follow-up care or treatment outcomes - Any subject currently involved in any personal injury litigation, medical-legal or worker's compensations claims - Any subject unable to read and understand English |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Corin |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Posterior condylar offset (PCO) | Any difference in PCO from preoperative to 6 weeks post-surgery | 6 weeks post-op | |
Secondary | Joint line in extension | Any difference in vertical distance from medial epicondyle to distal medial femoral condyle articular surface from preoperative to 6 weeks post-surgery | 6 weeks post-op | |
Secondary | Joint line in flexion | Any difference in medial joint line position measured using the PCO | 6 weeks post-op | |
Secondary | Femoral flexion angle | 6 weeks post-op | ||
Secondary | Distal femoral component angle | 6 weeks post-op | ||
Secondary | Tibial component angle | 6 weeks post-op | ||
Secondary | Tibial slope | 6 weeks post-op | ||
Secondary | Hip-knee-ankle (HKA) angle | 6 weeks post-op | ||
Secondary | Oxford Knee Score (OKS) | Up to 24 months post-op | ||
Secondary | Knee injury and Osteoarthritis Score - Physical Function Shortform (KOOS-PS) | Up to 24 months post-op | ||
Secondary | EuroQoL 5-dimension health state (EQ-5D 5-level) | Up to 6 months post-op | ||
Secondary | Hospital Anxiety and Depression Scale (HADS) | Up to 6 months post-op |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04226131 -
MusculRA: The Effects of Rheumatoid Arthritis on Skeletal Muscle Biomechanics
|
N/A | |
Completed |
NCT04171414 -
A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis
|
Phase 3 | |
Completed |
NCT02833350 -
Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA)
|
Phase 2 | |
Completed |
NCT04255134 -
Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN)
|
Phase 4 | |
Recruiting |
NCT05615246 -
Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)
|
||
Completed |
NCT03248518 -
Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases
|
N/A | |
Completed |
NCT03514355 -
MBSR in Rheumatoid Arthritis Patients With Controlled Disease But Persistent Depressive Symptoms
|
N/A | |
Recruiting |
NCT06005220 -
SBD121, a Synbiotic Medical Food for RA Management
|
N/A | |
Recruiting |
NCT05451615 -
Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis
|
Phase 3 | |
Completed |
NCT05054920 -
Eccentric Versus Concentric Exercises for Rotator Cuff Tendinopathy in Patients With Rheumatoid Arthritis
|
N/A | |
Completed |
NCT02037737 -
Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting
|
N/A | |
Recruiting |
NCT04079374 -
Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel
|
Phase 3 | |
Completed |
NCT02504268 -
Effects of Abatacept in Patients With Early Rheumatoid Arthritis
|
Phase 3 | |
Recruiting |
NCT05496855 -
Remote Care in People With Rheumatoid Arthritis
|
N/A | |
Completed |
NCT05051943 -
A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
|
||
Recruiting |
NCT06031415 -
Study of GS-0272 in Participants With Rheumatoid Arthritis
|
Phase 1 | |
Recruiting |
NCT06103773 -
A Study of Single and Multiple Oral Doses of TollB-001
|
Phase 1 | |
Completed |
NCT05999266 -
The Cartilage and Muscle Thickness on Knee Pain in Patients With Rheumatoid Arthritis
|
||
Recruiting |
NCT05302934 -
Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty
|
||
Recruiting |
NCT04169100 -
Novel Form of Acquired Long QT Syndrome
|
Phase 4 |